SecSonar.com

LivaNova PLC (LIVN)

LivaNova PLC at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

LivaNova PLC (LIVN) is a Medical - Devices company based in GB with a market capitalization of $4B. Revenue grew 10.7% year-over-year and the company generated $173.2M in free cash flow. This page tracks LIVN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 2.9K employees · IPO Oct 19, 2015

Valuation

Valuation & price

$70.00 · as of May 17, 2026 · -16.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.37

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$81.55$61.87$42.19Jul 25Dec 25Jun 26Jul 7, 25$45.58Jul 9, 25$47.17Jul 11, 25$44.33Jul 15, 25$43.43Jul 17, 25$42.54Jul 21, 25$42.35Jul 23, 25$44.12Jul 25, 25$43.67Jul 29, 25$43.99Jul 31, 25$42.19Aug 4, 25$42.76Aug 6, 25$47.36Aug 8, 25$48.84Aug 12, 25$50.64Aug 14, 25$54.13Aug 19, 25$53.48Aug 21, 25$52.86Aug 25, 25$56.35Aug 27, 25$56.49Aug 29, 25$56.37Sep 3, 25$56.59Sep 5, 25$57.97Sep 9, 25$58.72Sep 11, 25$57.34Sep 15, 25$55.43Sep 17, 25$54.53Sep 19, 25$55.00Sep 23, 25$53.96Sep 25, 25$52.28Sep 29, 25$52.33Oct 2, 25$51.23Oct 6, 25$52.63Oct 8, 25$53.37Oct 10, 25$50.69Oct 14, 25$52.77Oct 16, 25$53.89Oct 20, 25$54.10Oct 22, 25$54.85Oct 24, 25$54.89Oct 28, 25$53.86Oct 30, 25$52.79Nov 3, 25$52.58Nov 5, 25$50.81Nov 7, 25$50.45Nov 11, 25$52.68Nov 14, 25$55.36Nov 18, 25$53.89Nov 20, 25$53.42Nov 24, 25$60.46Nov 26, 25$63.84Dec 1, 25$63.11Dec 3, 25$63.29Dec 5, 25$63.36Dec 9, 25$62.01Dec 11, 25$63.95Dec 15, 25$63.06Dec 17, 25$63.08Dec 19, 25$62.82Dec 23, 25$63.25Dec 26, 25$62.87Dec 31, 25$61.53Jan 5, 26$63.23Jan 7, 26$64.62Jan 9, 26$64.41Jan 13, 26$61.33Jan 15, 26$63.19Jan 20, 26$62.92Jan 22, 26$63.88Jan 26, 26$64.20Jan 28, 26$63.91Jan 30, 26$65.71Feb 3, 26$65.93Feb 5, 26$65.03Feb 9, 26$65.74Feb 11, 26$66.43Feb 17, 26$66.96Feb 19, 26$67.89Feb 23, 26$68.35Feb 25, 26$70.29Feb 27, 26$70.60Mar 3, 26$68.43Mar 5, 26$64.70Mar 9, 26$62.06Mar 11, 26$62.26Mar 13, 26$58.46Mar 17, 26$62.43Mar 19, 26$63.53Mar 23, 26$63.24Mar 25, 26$63.30Mar 27, 26$61.85Apr 1, 26$64.63Apr 6, 26$63.50Apr 8, 26$64.66Apr 10, 26$62.78Apr 14, 26$64.99Apr 16, 26$65.01Apr 20, 26$65.81Apr 22, 26$65.18Apr 24, 26$64.20Apr 28, 26$61.29Apr 30, 26$60.10May 4, 26$59.07May 6, 26$66.26May 8, 26$71.86May 12, 26$71.75May 15, 26$70.00May 19, 26$72.92May 21, 26$73.64May 26, 26$75.42May 28, 26$73.04Jun 1, 26$73.81Jun 3, 26$71.33Jun 5, 26$72.36Jun 9, 26$77.17Jun 11, 26$79.94Jun 15, 26$79.70Jun 17, 26$78.50Jun 22, 26$78.71Jun 24, 26$79.95Jun 30, 26$81.55
$41.1352-week range$83.43
Loading valuation history…

Fundamentals

Key fundamentals

$4B

Market cap

10.7%

Revenue growth (YoY)

67.7%

Gross margin

$173.2M

Free cash flow (USD)

-$162.3M

Net debt

Net cash position

0.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.2BFY 2017$1.0BFY 2018$1.1BFY 2019$1.1BFY 2020$934.2MFY 2021$1.0BFY 2022$1.0BFY 2023$1.2BFY 2024$1.3BFY 2025$1.4B
$1.2B$1.4B

Free cash flow by year

2016 → 2025

FY 2016$53.0MFY 2017$57.2MFY 2018$82.5MFY 2019$-115.8MFY 2020$-114.4MFY 2021$77.1MFY 2022$43.4MFY 2023$39.9MFY 2024$135.9MFY 2025$173.2M
$53M$173.2M

Gross margin by year

2021 → 2025

FY 202168.2%FY 202269.2%FY 202366.9%FY 202469.5%FY 202567.7%
68.2%67.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $96KBianchi Francesco · Director · $96.2KJun 17, 2026Filing
  • 8-K eventAnnual General Meeting ResultsJun 11, 2026Filing
  • Insider sellInsider Sell $136KBianchi Francesco · Director · $136.4KMay 27, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is LivaNova PLC's market cap?

LivaNova PLC (LIVN) has a market capitalization of $4B.

What is LIVN's P/E ratio?

A meaningful P/E ratio is not available for LIVN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is LIVN's price-to-book (P/B) ratio?

LIVN trades at 3.37 times book value per share.

Are insiders buying LIVN stock?

SEC Form 4 filings show no open-market insider buys at LivaNova PLC in the last 90 days (2 sells).

Same arena

Related companies in Medical - Devices

IRTC

iRhythm Technologies, Inc.

$3.8B

ITGR

Integer Holdings Corporation

$3.1B

TMDX

TransMedics Group, Inc.

$2.3B

ESTA

Establishment Labs Holdings Inc.

$2.1B

AXGN

AxoGen, Inc.

$2.1B

GKOS

Glaukos Corporation

$6.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.